This medication is an anticholinergic and barbiturate combination, prescribed for Irritable Bowel Syndrome and intestinal inflammation.
Contraindicated in patients with increased eye pressure, gastrointestinal obstruction, urinary obstruction, heart problem with severe bleeding, muscle problem, alcohol abuse, history of excitement after taking phenobarbital drugs and hypersensitivity.
Dose is based on patients condition.
The recommended dose is one tablet every twelve (12) hours.
It comes as a tablet to take by mouth, 30 minutes before meals and at bedtime.
Caution should be exercised in patients with history of nerve problems, prostate problems, heart problems, hernia, diarrhea, fever, kidney or liver problems, gallbladder problems, breathing problems, overactive thyroid, high blood pressure, difficulty in urinating, ulcer, depression, suicidal thoughts, shock, alcohol addiction, any allergy, who are taking other medications, elderly, children, during pregnancy and breastfeeding.
It may cause dizziness, drowsiness, blurred vision or lightheadedness, do not drive a car or operate machinery while taking this medication.
Avoid alcohol consumption.
Dry mouth, nausea, vomiting, constipation and abdominal bloating.
Heart : Fast heart rate and palpitations.
Central Nervous System : Headache, dizziness, sleeplessness, excitement, agitation, drowsiness, nervousness and weakness.
Eye and ENT : Increased eye pressure, blurred vision, dilation of the pupils and loss of taste.
Genitourinary : Impotence, suppression of lactation, urinary hesitancy and retention.
Miscellaneous Musculoskeletal pain, severe allergic reactions including anaphylaxis, hives and other skin manifestations and decreased sweating.
Avoid becoming over heated; otherwise it may lead to heatstroke.
It may cause photosensitivity; wear sunglasses.
Store it at 20-25°C.
Subscribe to our Free Newsletters!
Collagen plays a crucial role in glowing skin, strong nails and shiny hair. You can boost collagen ...
CRISPR technology is a simple but potent tool for editing any part of the genome (complete set of ...
FDA recently approved Mogamulizumab-kpkc, a human monoclonal antibody prescribed for adult ...View All